IL11RA and prostate carcinoma: Because of the increased stage-specific expression of IL-11Rα on prostate cancer cells and tumor endothelium during disease progression, this peptide could serve as a ligand for the targeted delivery of drugs and imaging agents in patients with prostate cancer [66].